Advisor Group’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Advisor Group’s Portfolio STAB Stock Details STAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$0	Hold	25	–	–	﹤0.01%	5509
2019 Q3	$0	Hold	25	–	–	﹤0.01%	5495
2019 Q2	$0	Hold	25	–	–	﹤0.01%	5426
2019 Q1	$0	Hold	25	–	–	﹤0.01%	5387
2018 Q4	$0	Hold	25	–	–	﹤0.01%	5305
2018 Q3	$0	Hold	25	–	–	﹤0.01%	5282
2018 Q2	$0	Hold	25	–	–	﹤0.01%	5098
2018 Q1	$0	Hold	25	–	–	﹤0.01%	5117
2017 Q4	$0	Sell	25 -12	-32%	-$36	﹤0.01%	5114
2017 Q3	$0	Hold	37	–	–	﹤0.01%	4997
2017 Q2	$0	Hold	37	–	–	﹤0.01%	4954
2017 Q1	$0	Hold	37	–	–	﹤0.01%	4841
2016 Q4	$0	Hold	37	–	–	﹤0.01%	4681
2016 Q3	$0	Hold	37	–	–	﹤0.01%	4662
2016 Q2	$0	Buy	+37	New	+$87	﹤0.01%	4547

Other funds holding STAB

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Advisor Group's STAB Position: Q4 2019 in Review

Advisor Group held its Statera Biopharma, Inc. Common Stock (STAB) position steady in Q4 2019 at 25 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5509.

Advisor Group first reported a position in STAB in Q2 2016 and has held it in 15 quarters since. 14 funds tracked by Wall St. Rank hold STAB as of Q4 2019.

Advisor Group held 25 shares of Statera Biopharma, Inc. Common Stock worth $0 as of Q4 2019.
Advisor Group left its Statera Biopharma, Inc. Common Stock share count unchanged in Q4 2019.
Statera Biopharma, Inc. Common Stock made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5509 holding.
Advisor Group first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2016 and has held it in 15 quarters since.
14 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.